Greenleaf Health

Name

Greenleaf Health

Legal name

Greenleaf Health

Website

https://greenleafhealth.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

Greenleaf Health is a Washington, D.C.-based regulatory consulting firm providing FDA compliance, submission strategy, and lifecycle regulatory support to pharmaceutical, biotechnology, and medical device companies. It operates within the ELIQUENT Life Sciences platform (formerly Validant Group).

Ownership category

akta.pro rank

Product category

Regulatory Consulting

akta.pro primary industry

Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA)

akta.pro secondary industries

Regulatory Operations & Publishing (eCTD, RIM, Submission Management) (HLAGAKAC), Clinical Trials Authorization & Oversight (GCP) (HLAJADAF)

Keywords

• Regulatory consulting
• FDA compliance services
• Life sciences consulting
• Medical device regulatory
• Pharmaceutical regulatory strategy

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Regulatory Consulting Services: Professional services revenue model providing regulatory compliance expertise to life sciences companies. Services likely include regulatory strategy, submissions, and compliance consulting throughout the product lifecycle.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Greenleaf Health is a regulatory consulting firm that provides expert guidance and professional services to life sciences companies on FDA regulatory compliance. The firm supports clients across pharmaceutical, biotechnology, and medical device sectors with regulatory strategy, product submissions, and lifecycle compliance, and now operates as part of ELIQUENT Life Sciences (the unified brand of the Validant Group of companies).

Differentiator

Problem solved

Functional benefit

Products and services

• FDA Regulatory Consulting Services

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered flagship, core and minor.

• ELIQUENT Life SciencesflagshipOthersGreenleaf Health has united with other Validant Group companies (Validant, Oriel, IDEC, DataRevive, and Rapport) under the single ELIQUENT Life Sciences brand. This unification represents a strategic consolidation of regulatory expertise companies to provide comprehensive regulatory excellence services from thought to finish.
• Validant GroupcoreOthersValidant Group is the parent organization that has consolidated its portfolio companies including Greenleaf Health, Validant, Oriel, IDEC, DataRevive, and Rapport under the ELIQUENT Life Sciences brand to redefine regulatory excellence.
• OrielminorOthersSister company within the Validant Group portfolio, now operating under ELIQUENT Life Sciences. Part of the unified regulatory expertise ecosystem.
• IDECminorOthersSister company within the Validant Group portfolio, now operating under ELIQUENT Life Sciences. Part of the unified regulatory expertise ecosystem.
• DataReviveminorOthersSister company within the Validant Group portfolio, now operating under ELIQUENT Life Sciences. Part of the unified regulatory expertise ecosystem.
• RapportminorOthersSister company within the Validant Group portfolio, now operating under ELIQUENT Life Sciences. Part of the unified regulatory expertise ecosystem.

Scale indicators1 record

Direct peers

• PharmaLex (Cencora): PharmaLex, now part of Cencora/Allergan Aesthetics, provides regulatory affairs, pharmacovigilance, and quality consulting to life sciences companies globally. Direct peer to Greenleaf in regulatory strategy and submission services with similar GxP consulting depth.
• ProPharma Group: ProPharma Group provides regulatory, compliance, and quality consulting services to pharmaceutical, biotechnology, and medical device companies. Direct competitor to Greenleaf in the regulatory affairs consulting space with similar client base, similar GxP-focused service portfolio, and similar professional services model.
• The FDA Group: The FDA Group is a regulatory and quality consulting firm serving life sciences companies with FDA compliance, validation, and submission services. Highly comparable to Greenleaf in target customers (pharma/biotech/medical device firms), service lines (FDA regulatory consulting), and business model (boutique B2B professional services).
• Biologics Consulting Group: Biologics Consulting Group is a specialized regulatory consulting firm assisting biologics, biosimilars, and advanced therapy clients with FDA submissions and strategy. Closely aligned with Greenleaf in regulatory strategy, FDA interactions, and life sciences client focus.

Broad incumbents

• Parexel International: Parexel is a large global CRO offering regulatory consulting alongside clinical, commercialization, and post-approval services. While much broader than Greenleaf, its regulatory affairs practice competes for the same pharma/biotech clients and engagements.
• ICON plc: ICON plc is a global CRO providing clinical, regulatory, and consulting services to biopharma. Its regulatory consulting arm overlaps with Greenleaf's offerings and competes for similar large-pharma and biotech mandates.
• IQVIA: IQVIA is a leading global CRO with substantial regulatory affairs and compliance consulting offerings serving pharma and biotech. Much larger and broader than Greenleaf, but competes head-to-head on regulatory strategy and FDA submissions at the enterprise tier.
• Covington & Burling (FDA Practice): Covington & Burling is an international law firm with a leading FDA regulatory practice advising pharma, biotech, and medical device companies. While legal-led rather than consulting-led, it competes for regulatory strategy mandates overlapping with Greenleaf's FDA work.

Others

• Validant: Validant is a sister company under ELIQUENT Life Sciences providing broader regulatory consulting including quality and compliance to life sciences firms. Sister company in the same parent portfolio, partially overlapping in offerings but distinct under the unified brand.
• Oriel STAT A La Mode: Oriel (STAT A La Mode) is a sister firm under ELIQUENT Life Sciences providing statistical, clinical, and regulatory services. Sister company within the same parent portfolio with overlapping regulatory and quality offerings relevant for cross-firm collaboration.

Market position

Customer concentration

• Xx.com/greenleafhealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Greenleaf Health